Guidelines

Bevacizumab , sorafenib, sunitinib and temsirolimus for the treatment of advanced metastatic renal cell carcinoma

Docplexus Admin

Medical Writer

📅 08 Sep 2015 🕐 1 min read + Follow

Bevacizumab , sorafenib, sunitinib and temsirolimus for the treatment of advanced metastatic renal cell carcinoma

Under Renal Cancer section from NICE Technology Appraisal Guidelines published on August 2009

View Original Article on Docplexus ↗

13 0 0

Join the community and view the full post,
write comments and share this post.

🩺 India's Largest Platform for Doctors ✅ 5,10,000+ Verified Doctors 💬 60,000+ Clinical Discussions